24 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp04354 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | BT-474 | Breast cancer | IC50 : 34.5 µM |
| dbacp04355 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | T-47D | Breast cancer | IC50 : 14.1 µM |
| dbacp04356 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | SK-BR-3 | Breast cancer | IC50 : 25.7 µM |
| dbacp04357 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | MDA-MB-231 | Breast cancer | IC50 : 27.0 µM |
| dbacp04358 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | BT-20 | Breast cancer | IC50 : 20.0 µM |
| dbacp04359 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | ZR75-1 | Breast cancer | IC50 : 19.4 µM |
| dbacp04360 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | SF-295 | Brain tumor | IC50 : 19.1 µM |
| dbacp04361 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | SN-19 | Brain tumor | IC50 : 21.9 µM |
| dbacp04362 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | U-251 | Brain tumor | IC50 : 17.0 µM |
| dbacp04363 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | HuCCT-1 | Human epithelial cancer | IC50 : 17.1 µM |
| dbacp04364 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | LNCaP | Prostate cancer | IC50 : 15.8 µM |
| dbacp04365 | Lytic | KLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | COLO-587 | Human epithelial cancer | IC50 : 13.5 µM |
| dbacp06329 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | BT-474 | Breast cancer | IC50 : 8.8 µM |
| dbacp06330 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | T-47D | Breast cancer | IC50 : 4.0 µM |
| dbacp06331 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | SK-BR-3 | Breast cancer | IC50 : 6.5 µM |
| dbacp06332 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | MDA-MB-231 | Breast cancer | IC50 : 7.8 µM |
| dbacp06333 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | BT-20 | Breast cancer | IC50 : 4.8 µM |
| dbacp06334 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | ZR75-1 | Breast cancer | IC50 : 9.3 µM |
| dbacp06335 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | SF-295 | Brain tumor | IC50 : 6.3 µM |
| dbacp06336 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | SN-19 | Brain tumor | IC50 : 7.8 µM |
| dbacp06337 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | U-251 | Brain tumor | IC50 :7.0 µM |
| dbacp06338 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | HuCCT-1 | Human epithelial cancer | IC50 : 8.3 µM |
| dbacp06339 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | LNCaP | Prostate cancer | IC50 : 6.2 µM |
| dbacp06340 | Transferrin receptor (TfR)-lytic hybrid peptide | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | Transferrin receptor (TfR) | Disintegration of cell membrane | WST-1 assay | COLO-587 | Human epithelial cancer | IC50 : 6.4 µM |